Unusual Machines, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
UMAC$12.59-6.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Condensed Statements of Cash Flows
Consolidated Condensed Statement of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $10,282,994 | $(3,266,279) |
| Depreciation and amortization | 64,813 | 20,593 |
| Share-based compensation expense | 3,939,979 | 1,906,373 |
| Unrealized gain on short term investments | (9,492,076) | – |
| Realized gain on short term investments | (7,264,743) | – |
| Change in assets and liabilities: | ||
| Accounts receivable | (1,817,598) | 15,625 |
| Inventory | (8,510,541) | 121,213 |
| Prepaid inventory | (3,817,595) | 69,449 |
| Other assets | (428,004) | (173,647) |
| Right of use asset | (667,125) | 17,264 |
| Accounts payable and accrued expenses | (435,307) | 191,822 |
| Operating lease liabilities | 697,772 | (16,095) |
| Deferred revenue and other current liabilities | 34,443 | (79,946) |
| Net cash used in operating activities | (17,412,987) | (1,193,628) |
| Cash flows from investing activities | ||
| Purchase of short term investments | (17,500,000) | – |
| Proceeds from sale of short-term investments | 12,814,743 | – |
| Purchase of property and equipment | (698,237) | – |
| Net cash used in investing activities | (5,383,494) | – |
| Cash flows from financing activities: | ||
| Gross proceeds from issuance of common shares, public offering | 149,999,993 | – |
| Proceeds from option exercises | 260,334 | – |
| Proceeds from issuance of common shares, warrant exercises | 3,395,000 | 2,436,966 |
| Common share issuance offering costs | (11,200,000) | – |
| Net cash provided by financing activities | 142,455,327 | 2,436,966 |
| Net increase in cash and cash equivalents | 119,658,846 | 1,243,338 |
| Effect of exchange rates changes on cash | 19,431 | – |
| Cash and cash equivalents, beginning of period | 103,261,397 | 3,757,323 |
| Cash and cash equivalents, end of period | $222,939,674 | $5,000,661 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.